Stock listing
NASDAQ:ITCI Intra-Cellular Therapies Inc Stock
Follow Intra-Cellular Therapies Inc into a list and get an email when it puts out news.
Last close · NASDAQ:ITCI
$131.87 USD
Close on Apr 1, 2025 · No longer trades
- Lowest – highest close
- $7.26 – $131.92 USDSince Dec 27, 2013 · lowest Oct 1, 2019 · highest Mar 31, 2025
Delisted NASDAQ:ITCI no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ITCI
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Intra-Cellular Therapies Inc on 6ix
- Calls
- 10 calls with a replay · 10 with a transcript · latest Oct 30, 2024
- Decks
- 2 decks · latest Feb 25, 2025
Events
| Call | When | Status |
|---|---|---|
| Intra-Cellular Therapies (ITCI) Q3 2024 Earnings Call | Wed, Oct 30, 2024 · 8:30 AM ET | Replay |
| Intra-Cellular Therapies (ITCI) Q2 2024 Earnings Call | Wed, Aug 07, 2024 · 8:30 AM ET | Replay |
| Intra-Cellular Therapies (ITCI) Q1 2024 Earnings Call | Tue, May 07, 2024 · 8:30 AM ET | Replay |
| Intra-Cellular Therapies (ITCI) Q4 2023 Earnings Call | Thu, Feb 22, 2024 · 8:30 AM ET | Replay |
| Intra-Cellular Therapies (ITCI) Q3 2023 Earnings Call | Thu, Nov 02, 2023 · 8:30 AM ET | Replay |
| Intra-Cellular Therapies (ITCI) Q2 2023 Earnings Call | Thu, Aug 03, 2023 · 8:30 AM ET | Replay |
| Intra-Cellular Therapies (ITCI) Q1 2023 Earnings Call | Thu, May 04, 2023 · 8:30 AM ET | Replay |
| Intra-Cellular Therapies (ITCI) Q1 2022 Earnings Call | Tue, May 10, 2022 · 8:30 AM ET | Replay |
| Intra-Cellular Therapies (ITCI) Q3 2021 Earnings Call | Tue, Nov 09, 2021 · 8:30 AM ET | Replay |
| Intra-Cellular Therapies (ITCI) Q2 2021 Earnings Call | Mon, Aug 09, 2021 · 8:30 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (February 2025) | Merger or acquisition | 12 slides | Feb 25, 2025 |
| Investor Presentation (January 2018) | Investor deck | 28 slides | Jan 8, 2018 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Christopher D Alafi Other companies: Stereotaxis, Inc. (Director · Jan 3, 2012 – May 7, 2012 · Past) | Director · Aug 29, 2013 – May 27, 2021 · Past |
| Eduardo Rene Salas Other companies: ADMA Biologics Inc (Director · Since at least Dec 30, 2024) | Director · Jun 14, 2024 – Apr 2, 2025 · Past |
| Mark Neumann Other companies: Veradermics, Incorporated (Chief Commercial Officer · Since at least Feb 3, 2026) | EVP, Chief Commercial Officer · Oct 15, 2018 – Apr 2, 2025 · Past |
| Robert L. Van Nostrand Other companies: SELLAS Life Sciences Group, Inc. (Director · Since at least Feb 2, 2023) | Director · Mar 31, 2022 – Apr 2, 2025 · Past |
| Allen A Fienberg | VP of Business Development · Aug 29, 2013 – Aug 19, 2015 · Past |
| Lawrence J Hineline | SVP of Finance, CFO · Jan 3, 2018 – Mar 7, 2024 · Past |
| Michael Halstead | President · Nov 17, 2020 – Apr 2, 2025 · Past |
Log in to ask 6ix AI your own questions about Intra-Cellular Therapies Inc.